Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7


Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.

Zhang S, Sun X, Chang W, Dai Y, Ma X.

PLoS One. 2015 Aug 19;10(8):e0136082. doi: 10.1371/journal.pone.0136082. eCollection 2015. Review.


Low prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates among Connecticut veterans.

Fink SL, Martinello RA, Campbell SM, Murray TS.

Antimicrob Agents Chemother. 2012 Jan;56(1):582-3. doi: 10.1128/AAC.05024-11. Epub 2011 Nov 7.


Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

van Hal SJ, Paterson DL.

Antimicrob Agents Chemother. 2011 Jan;55(1):405-10. doi: 10.1128/AAC.01133-10. Epub 2010 Nov 15. Review.


Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients.

Loomba PS, Taneja J, Mishra B.

J Glob Infect Dis. 2010 Sep;2(3):275-83. doi: 10.4103/0974-777X.68535.


Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections.

Dombrowski JC, Winston LG.

J Infect. 2008 Aug;57(2):110-5. doi: 10.1016/j.jinf.2008.04.003. Epub 2008 Jun 3.


Intermediate vancomycin susceptibility in a community-associated MRSA clone.

Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF.

Emerg Infect Dis. 2007 Mar;13(3):491-3.


Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center.

Maor Y, Rahav G, Belausov N, Ben-David D, Smollan G, Keller N.

J Clin Microbiol. 2007 May;45(5):1511-4. Epub 2007 Mar 7.

Supplemental Content

Support Center